Modulatory roles of the NPFF system in pain mechanisms at the spinal level

Peptides

Volumn 27, Issue 5, 2006, Pages 943-952

  Yang, Hsiu Ying T ^a   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Inflammation; Nociception; NPFF; NPFF receptor; RF NH2 peptides; Spinal level

Indexed keywords

ANALGESIC AGENT; ION CHANNEL; MESSENGER RNA; MORPHINE; NEUROPEPTIDE FF;

BIOLOGICAL ACTIVITY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN; RHIZOTOMY; SHORT SURVEY; SPINAL CORD; SPINAL GANGLION;

AMINO ACID SEQUENCE; ANALGESIA; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN; RECEPTORS, NEUROPEPTIDE; SEQUENCE ALIGNMENT; SPINAL CORD;

ANIMALIA;

EID: 33646146196     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.06.030     Document Type: Short Survey

References (76)

1. Aarnisalo A.A., and Panula P. Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: a Phaseolus vulgaris leucoagglutinin study. Neuroscience 65 (1995) 175-192
2. Allard M., Geoffre S., Legendre P., Vincent J.D., and Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res 500 (1989) 169-176
3. Allard M., Jordan D., Zajac J.M., Ries C., Martin D., Monkouanga D., et al. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res 633 (1994) 127-132
4. Allard M., Rousselot P., Lombard M.C., and Theodosis D.T. Evidence for neuropeptide FF (FLFQRFamide) in rat dorsal root ganglia. Peptides 20 (1999) 327-333
5. Allard M., Theodosis D.T., Rousselot P., Lombard M.C., and Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: biochemical and immunocytochemical studies. Neuroscience 40 (1991) 81-92
6. Allard M., Zajac J.M., and Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 49 (1992) 101-116
7. Askwith C.C., Cheng C., Ikuma M., Benson C., Price M.P., and Welsh M.J. Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. Neuron 26 (2000) 133-141
8. Altier N., Dray A., Menard D., and Henry J.L. Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration. Eur J Pharmacol 407 (2000) 245-255
9. Ballet S., Mauborgne A., Gouarderes C., Bourgoin A.S., Zajac J.M., Hamon M., et al. The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology 38 (1999) 1317-1324
10. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J.M., et al. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides 22 (2001) 01085-01092
11. Bonnard E., Burlet-Schiltz O., Monsarrat B., Girard J.P., and Zajac J.M. Identification of proNeuropeptide FFA peptides processed in neuronal and non-neuronal cells and in nervous tissue. Eur J Biochem 270 (2003) 4187-4199
12. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
13. Burlet-Schiltz O., Mazarguil H., Sol J.C., Chaynes P., Monsarrat B., Zajac J.M., et al. Identification of neuropeptide FF-related peptides in human cerebrospinal fluid by mass spectrometry. FEBS Lett 532 (2002) 313-318
14. Catarsi S., Babinski K., and Seguela P. Selective modulation of heteromeric ASIC proton-gated channels by neuropeptide FF. Neuropharmacology 41 (2001) 592-600
15. Chartrel N., Dujardin C., Anouar Y., Leprince J., Decker A., Clerens S., et al. Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Proc Natl Acad Sci U S A 100 (2003) 15247-15252
16. Courteix C., Coudore-Civiale M.A., Privat A.M., Zajac J.M., Eschalier A., and Fialip J. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats. Br J Pharmacol 127 (1999) 1454-1462
17. Deval E., Baron A., Lingueglia E., Mazarguil H., Zajac J.M., and Lazdunski M. Effects of neuropeptide SF and related peptides on acid sensing ion channel 3 and sensory neuron excitability. Neuropharmacology 44 (2003) 662-671
18. Dockray G.J. The expanding family of -RFamide peptides and their effects on feeding behaviour. Exp Physiol 89 (2004) 229-235 Review
19. Dockray G.J., Reeve Jr. J.R., Shively J., Gayton R.J., and Barnard C.S. A novel active pentapeptide from chicken brain identified by antibodies to FMRFamide. Nature 305 (1983) 328-330
20. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., et al. Receptor for the pain modulating neuropeptide FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275 (2000) 25965-25971
21. Gouardères C., Kar S., and Zajac J.-M. Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord. Neuroscience 74 (1996) 21-27
22. Gouarderes C., Roumy M., Advokat C., Jhamandas K., and Zajac J.M. Dual localization of neuropeptide FF receptors in the rat dorsal horn. Synapse 35 (2000) 45-52
23. Gouarderes C., Sutak M., Zajac J.M., and Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 237 (1993) 73-81
24. Greenberg M.J., Painter S.D., Doble K.E., Nagle G.T., Price D.A., and Lehman H.K. The molluscan neurosecretory peptide FMRFamide: comparative pharmacology and relationship to the enkephalins. Fed Proc 42 (1983) 82-86
25. Hinuma S., Habata Y., Fujii R., Kawamata Y., Hosoya M., Fukusumi S., et al. A prolactin-releasing peptide in the brain. Nature 393 (1998) 272-276
26. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nature Cell Biol 2 (2000) 703-708
27. Huang E.Y., Li J.Y., Tan P.P., Wong C.H., and Chen J.C. The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF). Peptides 21 (2000) 205-210
28. Hylden J.L., Thomas D.A., Iadarola M.J., Nahin R.L., and Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol 194 (1991) 135-143
29. Iadarola MJ, Mannes AJ, Karai L, Mitchell K, O'Donnell B, Wellisch O, et al. Neuropeptide FF receptor 2 up-regulation in dorsal root ganglion and dorsal spinal cord during peripheral inflammation, Society of Neuroscience Abstract 437.5. 2003.
30. Jhamandas J.H., and Mactavish D. Central administration of neuropeptide FF (NPFF) causes increased neuronal activation and up-regulation of NPFF gene expression in the rat brainstem. J Comp Neurol 447 (2002) 300-307
31. Jiang Y., Luo L., Gustafson E.L., Yadav D., Laverty M., Murgolo N., et al. Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155. J Biol Chem 278 (2003) 27652-27657
32. Joost P., and Methner A. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol 3 (2002) 63.1-63.16
33. Kalliomäki M.L., and Panula P. Neuropeptide FF, but not prolactin-releasing peptide, mRNA is differentially regulated in the hypothalamic and medullary neurons after salt loading. Neuroscience 124 (2004) 81-87
34. Kalliomäki M.L., Pertovaara A., Brandt A., Wei H., Pietila P., Kalmari J., et al. Prolactin-releasing peptide affects pain, allodynia and autonomic reflexes through medullary mechanisms. Neuropharmacology 46 (2004) 412-424
35. Kivipelto L., Majane E.A., Yang H.-Y.T., and Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide like peptides in the central nervous system of rats. J Comp Neurol 286 (1989) 269-287
36. Kivipelto L., and Panula P. Comparative distribution of neurons containing FLFQPQRFamide-like (morphine-modulating) peptide and related neuropeptides in the rat brain. Eur J Neurosci 3 (1991) 175-185
37. Kivipelto L., and Panula P. Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats. J Comp Neurol 307 (1991) 107-119
38. Kontinen V.K., Aarnisalo A.A., Idanpaan-Heikkila J.J., Panula P., and Kalso E. Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides 18 (1997) 287-292
39. Kotani M., Detheux M., Vandenbogaerde A., Communi D., Vanderwinden J.M., Le Poul E., et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276 (2001) 34631-34636
40. Laguzzi R., Nosjean A., Mazarguil H., and Allard M. Cardiovascular effects induced by the stimulation of neuropeptide FF receptors in the dorsal vagal complex: an autoradiographic and pharmacological study in the rat. Brain Res 711 (1996) 193-202
41. Lee C.H., Wasowicz K., Brown R., Majane E.A., Yang H.-Y.T., and Panula P. Distribution and characterization of neuropeptide FF-like immunoreactivity in the rat nervous system with a monoclonal antibody. Eur J Neurosci 5 (1993) 1339-1348
42. Lefrere I., De Coppet P., Camelin J.C., Le Lay S., Mercier N., Elshourbagy N., et al. Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness. J Biol Chem 277 (2002) 39169-39178
43. Lin S.H., Leslie F.M., and Civelli O. Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception. Brain Res 952 (2002) 15-30
44. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276 (2001) 36961-36969
45. Lombard M.C., Simonnet G., Zajac J.M., Besson J.M., and Allard M. Distribution of neuropeptide FF (FLFQPQRFamide) receptors in the adult rat spinal cord: effects of dorsal rhizotomy and neonatal capsaicin. Neuroscience 68 (1995) 1229-1235
46. Lombard M.C., Weil-Fugazza J., Ries C., and Allard M. Unilateral joint inflammation induces bilateral and time-dependent changes in neuropeptide FF binding in the superficial dorsal horn of the rat spinal cord: implication of supraspinal descending systems. Brain Res 816 (1999) 598-608
47. 2-like peptide. Brain Res 494 (1989) 1-12
48. Majane E.A., and Yang H.-Y.T. Distribution and characterization of two putative endogenous opioid antagonist peptides in bovine brain. Peptides 8 (1987) 657-662
49. 2-like peptide in rat pituitary: decrease by osmotic stimulus. Peptides 12 (1991) 1303-1308
50. Majane E.A., Zhu J., Aarnisalo A.A., Panula P., and Yang H.-Y.T. Origin of neurohypophyseal neuropeptide-FF (FLFQPQRF-NH2). Endocrinology 133 (1993) 1578-1584
51. Murase T., Arima H., Kondo K., and Oiso Y. Neuropeptide FF reduces food intake in rats. Peptides 17 (1996) 353-354
52. Nicklous D.M., and Simansky K.J. Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake. Am J Physiol Regul Integr Comp Physiol 285 (2003) 1046-1054
53. Nystedt J.M., Lemberg K., Lintunen M., Mustonen K., Holma R., Kontinen V.K., et al. Pain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor gene. Neurobiol Dis 16 (2004) 254-262
54. Panula P., Aarnissalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48 (1996) 461-487
55. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., and Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 848 (1999) 191-196 [Review]
56. Panula P., Kivipelto l., Nieminen O., Majane E.A., and Yang H.-Y.T. Neuroanatomy of morphine-modulating neuropeptides. Med Biol 65 (1987) 127-135
57. Payza K., and Yang H.-Y.T. Modulation of neuropeptide FF receptors by guanine nucleotides and cations in membranes of rat brain and spinal cord. J Neurochem 60 (1993) 1894-1899
58. Perry S.J., Huang E.Y.-K., Cronk D., Bagust J., Sharma R., Walker R.J., et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409 (1997) 426-430
59. Price D.A., and Greenberg M.J. Structure of a molluscan cardioexcitatory neuropeptide. Science 197 (1977) 670-671
60. Price M.P., McIlwrath S.L., Xie J., Cheng C., Qiao J., Tarr D.E., et al. The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice. Neuron 32 (2001) 1071-1083
61. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 (2001) 79-91
62. Roumy M., and Zajac J.-M. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345 (1998) 1-11 [Review]
63. Sundblom D.M., Kalso E., Tigerstedt I., Wahlbeck K., Panula P., and Fyhrquist F. Neuropeptide FF-like immunoreactivity in human cerebrospinal fluid of chronic pain patients and healthy controls. Peptides 18 (1997) 923-927
64. Sunter D., Hewson A.K., Lynam S., and Dickson S.L. Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. Neurosci Lett 313 (2001) 145-148
65. Ukena K., Iwakoshi E., Minakata H., and Tsutsui K. A novel rat hypothalamic RFamide-related peptide identified by immunoaffinity chromatography and mass spectrometry. FEBS Lett 512 (2002) 255-258
66. Ukena K., and Tsutsui K. Distribution of novel RFamide-related peptide-like immunoreactivity in the mouse central nervous system. Neurosci Lett 300 (2001) 153-156
67. Vilim F.S., Aarnisalo A.A., Nieminenn M.-L., Lintunen M., Karlsstedt K., Kontinen V.K., et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55 (1999) 804-811
68. Voilley N., de Weille J., Mamet J., and Lazdunski M. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21 (2001) 8026-8033
69. Waldmann R., and Lazdunski M. H(+)-gated cation channels: neuronal acid sensors in the NaC/DEG family of ion channels. Curr Opin Neurobiol 8 (1998) 418-424 Review
70. Xie J., Price M.P., Wemmie J.A., Askwith C.C., and Welsh M.J. ASIC3 and ASIC1 mediate FMRFamide-related peptide enhancement of H+-gated currents in cultured dorsal root ganglion neurons. J Neurophysiol 89 (2003) 2459-2465
71. Xu M., Kontinen V.K., Panula P., and Kalso E. Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models. Peptides 20 (1999) 1071-1077
72. Xu M., Kontinen V.K., Panula P., and Kalso E. Role of the delta-opioid receptor in (1DMe)NPYF mediated antinociception. Peptides 22 (2001) 33-38
73. Yang H.-Y.T., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A 93 (1985) 60025-60030
74. Yang H.-Y.T., and Iadarola M.J. Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats. Neuroscience 118 (2003) 179-187
75. Yudin Y.K., Tamarova Z.A., Ostrovskaya O.I., Moroz L.L., and Krishtal O.A. RFa-related peptides are algogenic: evidence in vitro and in vivo. Eur J Neurosci 20 5 (2004) 1419-1423
76. Zeng Z., McDonald T.P., Wang R., Liu Q., and Austin C.P. Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata. J Chem Neuroanat 25 (2003) 269-278